Ascendis Pharma A/S (FRA:A71)
Germany flag Germany · Delayed Price · Currency is EUR
206.00
+2.00 (0.98%)
Inactive · Last trade price on Apr 17, 2026

Ascendis Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-228.03-378.08-481.45-583.19-383.58
Depreciation & Amortization
17.2117.2518.4317.5114.95
Other Amortization
0.490.470.480.440.45
Loss (Gain) From Sale of Assets
--0.090.010.02-
Asset Writedown & Restructuring Costs
5.28-7.83--
Loss (Gain) on Equity Investments
-16.3120.0618.417.7-12.04
Stock-Based Compensation
116.1795.5166.6664.1866.83
Other Operating Activities
88.1345.852.070.11-56.53
Change in Accounts Receivable
15.59-118.61-32.77-11.53-6.66
Change in Inventory
-5.92-86.68-78.26-55.27-75.41
Change in Accounts Payable
-10.3726.973.5545.9439.19
Change in Unearned Revenue
0.13-1.2-7.088.655.2
Change in Other Net Operating Assets
71.5372.3614.77-0.26-10.05
Operating Cash Flow
53.9-306.2-467.36-495.7-417.65
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-8.49-1.43-2.44-14.49-23.7
Sale of Property, Plant & Equipment
-0.950.05--
Sale (Purchase) of Intangibles
-----0.53
Investment in Securities
-7.35288.8766.69-86.35
Other Investing Activities
---9.54-
Investing Cash Flow
-8.496.88286.4761.73-110.58

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
-134.16136.26503.28-
Long-Term Debt Repaid
-21.96-11.37-10.44-6.36-6.43
Net Debt Issued (Repaid)
-21.96122.79125.82496.93-6.43
Issuance of Common Stock
87.08340.4310.295.15379.42
Repurchase of Common Stock
-28.79--1.81-105.31-21.61
Other Financing Activities
--19.29---
Financing Cash Flow
36.33443.93134.29396.77351.39

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-25.2422.77-6.0135.6938.59
Net Cash Flow
56.5167.38-52.6-1.5-138.25

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
45.41-307.62-469.8-510.19-441.35
Free Cash Flow Growth
-----
Free Cash Flow Margin
6.31%-84.60%-176.14%-996.97%-5674.38%
Free Cash Flow Per Share
0.75-5.31-8.35-9.10-8.06
Levered Free Cash Flow
164.71-200.32-332.95-156.42-281.9
Unlevered Free Cash Flow
215.12-159.38-305.41-137.24-279.45

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Interest Paid
22.9415.2115.679.291.84
Cash Income Tax Paid
6.685.514.470-0.15
Change in Working Capital
70.96-107.16-99.79-12.47-47.72